BTLA and neoplasm: According to the previous research, combining PD-1 antibodies and BTLA antibodies might be of treatment effect in conditions in which tumor masses are non-homogeneous in terms of PD-1 and BTLA ligand expression (Celis-Gutierrez et al., 2019).